Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.

Pathophysiology of Haemostasis and Thrombosis Pub Date : 2007-01-01 Epub Date: 2010-03-13 DOI:10.1159/000296281
Takefumi Matsuo, Miyako Matsuo, Takaki Sugimoto, Keiko Wanaka
{"title":"Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.","authors":"Takefumi Matsuo,&nbsp;Miyako Matsuo,&nbsp;Takaki Sugimoto,&nbsp;Keiko Wanaka","doi":"10.1159/000296281","DOIUrl":null,"url":null,"abstract":"<p><p>Heparin-induced thrombocytopenia (HIT) is known to complicate disseminated intravascular coagulation (DIC), but rarely to be complicated by DIC. We measured the titers of anti-PF4/hepatin complex antibodies by ELISA (HIT-Elisa) and examined 4 parameters of coagulation and fibrinolysis [D-dimer, thrombin/antithrombin complex (TAT), plasmin/alpha2-plasmin inhibitor complex (PIC), and antithrombin levels] in 80 patients with DIC diagnosed by a DIC scoring system. Fourteen patients were HIT-Elisa-positive, 11 of whom received heparin. In 3 of these 11 patients, platelet counts were < or =10 x 10(9)/l and/or reduced by more than 50% for 5-10 days after the heparin (2 patients treated with renal replacement therapy for chronic uremia and postoperative renal failure, and 1 with DIC from a solid tumor). The 3 patients had an optical density reading of >1.0 and a high level of IgG for HIT antibodies, and were thus considered to have DIC complicated with HIT (DIC-HIT). The other 8 patients had optical density readings of 0.4-1.0, and it was unclear whether their thrombocytopenia was caused by HIT alone or by sustained DIC. There were no significant differences in platelet counts and the 4 parameters of coagulation and fibrinolysis between the patients with DIC-HIT and DIC patients with a weakly positive result (0.4-1.0). No differences were observed in platelet counts, or levels of D-dimer and antithrombin between HIT-Elisa-positive and -negative DIC patients. However, the HIT-Elisa-negative patients showed significantly higher levels of TAT and PIC, presumably reflecting DIC-related hypercoagulability. In conclusion, DIC patients treated with heparin occasionally showed HIT antibody seroconversion and developed HIT. HIT-Elisa could assist in the diagnosis of HIT.</p>","PeriodicalId":19817,"journal":{"name":"Pathophysiology of Haemostasis and Thrombosis","volume":"36 6","pages":"305-10"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000296281","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathophysiology of Haemostasis and Thrombosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000296281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2010/3/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

Heparin-induced thrombocytopenia (HIT) is known to complicate disseminated intravascular coagulation (DIC), but rarely to be complicated by DIC. We measured the titers of anti-PF4/hepatin complex antibodies by ELISA (HIT-Elisa) and examined 4 parameters of coagulation and fibrinolysis [D-dimer, thrombin/antithrombin complex (TAT), plasmin/alpha2-plasmin inhibitor complex (PIC), and antithrombin levels] in 80 patients with DIC diagnosed by a DIC scoring system. Fourteen patients were HIT-Elisa-positive, 11 of whom received heparin. In 3 of these 11 patients, platelet counts were < or =10 x 10(9)/l and/or reduced by more than 50% for 5-10 days after the heparin (2 patients treated with renal replacement therapy for chronic uremia and postoperative renal failure, and 1 with DIC from a solid tumor). The 3 patients had an optical density reading of >1.0 and a high level of IgG for HIT antibodies, and were thus considered to have DIC complicated with HIT (DIC-HIT). The other 8 patients had optical density readings of 0.4-1.0, and it was unclear whether their thrombocytopenia was caused by HIT alone or by sustained DIC. There were no significant differences in platelet counts and the 4 parameters of coagulation and fibrinolysis between the patients with DIC-HIT and DIC patients with a weakly positive result (0.4-1.0). No differences were observed in platelet counts, or levels of D-dimer and antithrombin between HIT-Elisa-positive and -negative DIC patients. However, the HIT-Elisa-negative patients showed significantly higher levels of TAT and PIC, presumably reflecting DIC-related hypercoagulability. In conclusion, DIC patients treated with heparin occasionally showed HIT antibody seroconversion and developed HIT. HIT-Elisa could assist in the diagnosis of HIT.

ELISA检测弥漫性血管内凝血患者抗肝素/PF4复合物的疗效。
肝素诱导的血小板减少症(HIT)已知会使弥散性血管内凝血(DIC)并发症,但很少合并DIC。我们采用ELISA (HIT-Elisa)检测了80例DIC患者的抗pf4 /肝蛋白复合物抗体滴度,并检测了凝血和纤溶的4个参数[d -二聚体、凝血酶/抗凝血酶复合物(TAT)、纤溶酶/ α 2-纤溶酶抑制剂复合物(PIC)和抗凝血酶水平]。14例患者hit - elisa阳性,其中11例接受肝素治疗。在这11例患者中,有3例患者在接受肝素治疗后5-10天内血小板计数<或=10 × 10(9)/l和/或减少了50%以上(2例患者因慢性尿毒症和术后肾功能衰竭而接受肾脏替代治疗,1例患者因实体瘤而发生DIC)。3例患者光密度读数>1.0,HIT抗体IgG水平较高,考虑DIC合并HIT (DIC-HIT)。其他8例患者的光密度读数为0.4-1.0,尚不清楚他们的血小板减少是由HIT单独引起的还是由持续的DIC引起的。弱阳性DIC- hit患者与弱阳性DIC患者血小板计数、凝血、纤溶4项指标差异无统计学意义(0.4-1.0)。hit - elisa阳性和阴性DIC患者的血小板计数、d -二聚体和抗凝血酶水平均无差异。然而,hit - elisa阴性的患者TAT和PIC水平明显升高,可能反映了dic相关的高凝性。综上所述,肝素治疗的DIC患者偶尔会出现HIT抗体血清转化并发生HIT。HIT- elisa可辅助HIT的诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信